Tarsus Pharmaceuticals DSO Ratio 2011-2026 | TARS

Annual DSO Ratio Tarsus Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
53.3	63.2	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
63.2	53.3	58.3

Quarterly DSO Ratio Tarsus Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
50.3	53.7	63.6	-	55.6	66.4	76.8	-	-	-	45.6	-	-	0.1	1.44	-	736	93.2	34.1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
736	0.1	106

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Ascendis Pharma A/S ASND	132	$ 229.25	0.44 %	$ 5 B	Danmark
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
AbbVie ABBV	258	$ 208.84	-2.86 %	$ 369 B	USA
AbCellera Biologics ABCL	173	$ 3.52	0.28 %	$ 1.05 B	Canada
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	3.58	$ 3.33	-2.06 %	$ 99 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Adaptive Biotechnologies Corporation ADPT	60.7	$ 14.81	2.63 %	$ 2.25 B	USA
Altimmune ALT	7.85 K	$ 3.34	7.05 %	$ 294 M	USA
Amgen AMGN	81.2	$ 347.94	-1.51 %	$ 187 B	USA
ANI Pharmaceuticals ANIP	114	$ 74.21	-2.3 %	$ 1.43 B	USA
Aravive ARAV	16.8	-	-13.39 %	$ 1.45 M	USA
Arcturus Therapeutics Holdings ARCT	21.2	$ 8.03	2.29 %	$ 220 M	Israel
Aurinia Pharmaceuticals AUPH	185	$ 15.61	0.9 %	$ 2.1 B	Canada
Autolus Therapeutics plc AUTL	58.2	$ 1.41	2.17 %	$ 375 M	Britain
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Aytu BioScience AYTU	150	$ 2.68	1.52 %	$ 16.8 M	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
BioCryst Pharmaceuticals BCRX	55.1	$ 9.02	-3.84 %	$ 1.86 B	USA
Axon Enterprise AXON	134	$ 412.81	-2.54 %	$ 31.3 B	USA
Alnylam Pharmaceuticals ALNY	58.1	$ 318.85	-3.01 %	$ 41.8 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel